Loading clinical trials...
Loading clinical trials...
An Open-Label, Rising Multiple-Dose, Multi-Center Study to Evaluate the Safety and Efficacy of Topically Applied AN2690 5.0% and 7.5% Solution for the Treatment of Adult Subjects With Onychomycosis of the Great Toenail
Conditions
Interventions
AN2690 Solution, 5.0%
AN2690 Solution, 7.5%
Locations
9
Mexico
Unidad de Investigación en Salud (UIS)
Chihuahua City, Mexico
Hospital "Dr. Angel Leaño"
Guadalajara, Mexico
Instituto Dermatologico Jalisciense
Guadalajara, Mexico
Centro Dermatologico Pascua
Mexico City, Mexico
CIF-BIOTEC Medica Sur.
Mexico City, Mexico
IMIC
Mexico City, Mexico
Start Date
November 1, 2005
Primary Completion Date
February 1, 2007
Completion Date
February 1, 2007
Last Updated
November 14, 2018
NCT06689852
NCT00233493
NCT06175013
NCT02022215
NCT06254027
NCT05809297
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions